Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer.
As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan\'s efficacy, its market size has been limited due to its high price. After entering the 21st century, lentinan has become able to be produced domestically at a relatively low price. Therefore, its market size grows at an increasing rate. Now, China is the dominate producer of lentinan, the production is 84528 Kg in 2015, according for about 67.85% of the total amount, followed by Japan, with the production market share of 15.72%. China also has the highest production growth rate of 6.00% from 2011 to 2015. Even though a huge space for growth in the Chinese market exists, the quality and technology should further improve.
The report offers detailed coverage of Lentinan industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Lentinan by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Lentinan market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Lentinan market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Ajinomoto
Elicityl
Nammex
Panjin Gerun Biotech
Golden Horizon Biologics
Acetar Bio-Tech
Johncan Mushroom Bio-technology
Xi'an Changyue Phychemistry
Xi'an Yuansun Biological
At the same time, we classify Lentinan according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Food Grade
Pharmaceutical Grade
Other
Market by Application
Food additive
Health product field
Anti-cancer drug
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Lentinan market for the forecast period 2021 - 2025?
• What are the driving forces in the Lentinan market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Lentinan industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?